Bulgaria’s Tchaikapharma gets shareholders nod for 14 mln euro loan for new plant
SOFIA (Bulgaria), February 23 (SeeNews) – Bulgarian drug maker Tchaikapharma High Quality Medicines [BUL:7TH] said that its shareholders have approved its plan to borrow up to 14 million euro ($
23 February, 2021A company of over one billion leva market capitalization on the BSE
At the beginning of February, one share of the company costs BGN 13.80, which means that the market capitalization of the pharmaceutical equals 1.13 billion leva. Read the full article here in Bulgari
03 February, 2021Engr. Biser Georgiev, Executive Director: With a market cap of over BGN 1 billion Tchaikapharma remains the most expensive public company
We say goodbye to a historic year, marked by unprecedented difficulties in medical, economical, political and of course, in pure human terms. With hard work and effective oganization, in this difficul
22 December, 2020Tchaikapharma remains the most expensive company
Tchaikapharma High Quality Medicines Inc. remains the most expensive Bulgarian company on the Bulgarian Stock Exchange. After the market capitalization of the pharmaceutical company exceeded BGN 1 bil
09 October, 2020Prof. Dr. Rasho Rashkov: Rheumatic patients are more protected than COVID-19 … especially those who take hydroxychloroquine
Patients with rheumatic disease are less likely to suffer from coronavirus, especially those taking hydroxychloroquine. That is why their therapy should not be interrupted during the pandemic, says rh
05 October, 2020Tchaikapharma retains its position as the most expensive Bulgarian company
Tchaikapharma High Quality Medicines retains its position as the most expensive Bulgarian company on the BSE. After the players on the stock exchange estimated the pharmaceutical company at BGN 1,027,
04 August, 2020There is a company on the BSE with a value of over one billion leva – this is Tchaikapharma!
There is a company on the Bulgarian Stock Exchange with a value of over a billion leva, according to data in the bulletin of the stock exchange operator for the second quarter. This is Tchaikapharma H
13 July, 2020Gen. Mutafchiyski: Hydroxychloroquine has not been rejected for treatment
Briefing at the Ministry of health
07 July, 2020Tchaikapharma International Press Center informs: Global COVID-19 prevention trial of hydroxychloroquine to resume
Global COVID-19 prevention trial of hydroxychloroquine to resume LONDON (Reuters) – A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent
30 June, 2020Tchaikapharma’s MoriVid is now available in pharmacies!
MoriVid (hydroxychloroquine sulfate) 200 mg, 30 tablets, expected by thousands of Bulgarian patients, is now available in the pharmacies countrywide. The distributor of the medicinal product is Commer
19 June, 2020Prof. Toni Vekov to BNT: I hope MoriVid to be available in all pharmacies as of next week
Prof. Toni Vekov – Director of the scientific board of Tchaikapharma, prof. Rasho Rashkov – Chairman of the Bulgarian Rheumatology Society and Boryana Boteva – Chairman of the Rheumatology Patients Or
16 June, 2020Tchaikapharma received approval for MoriVid (hydroxychloroquine sulfate 200 mg, film-coated tablets) needed by patients with Lupus and Rheumatoid Arthritis
(updated on 5 June, 14:30 ) In response to numerous inquiries from doctors, journalists and especially from patients suffering from autoimmune diseases, we confirm inform that Tchaikapharma High Quali
10 June, 2020Bulgaria’s Tchaikapharma plans to build third plant near Sofia
Tchaikapharma High Quality Medicines AD (BSE: 7TH) intends to build a third manufacturing plant in the village of Kazichene near Sofia. This became clear from documents published in the Commercial Reg
30 April, 2020Tchaikapharma will produce about 5,000 MoriVir packs within the next ten days
President Trump takes hydroxychloroquine to prevent coronavirus infection even though it’s an unproven treatment Professor Toni Vekov in an interview with NOVA: Tchaikapharma R&D Team worked aroun
13 April, 2020Tchaikapharma: The first 5000 packs of Hydroxychloroquine will be produced within a couple of days
Within a couple of days, Tchaikapharma is about to produce the first 5,000 MoriVir (hydroxychloroquin) packs for the front-line hospitals in the battle against COVID-19, and in May, another 20,000 Gra
08 April, 2020Tchaikapharma took part in the graduation ceremony of young pharmacists at the Varna Medical University
Tchaikapharma High Quality Medicines received a thank-you letter from Prof. Diana Ivanova, Ph.D., Dean of the Pharmacy Faculty at the Varna Medical University in connection with the “empathy and
05 March, 2020Tchaikapharma to build new manufacturing complex for tablets, capsules and liquid medicines
In 2019 Tchaikapharma (BSE:7TH) affirmed its leadership through successful development of scientific projects based on the advanced research on the development and integration of innovative combo medi
07 January, 2020Tchaikapharma’s employees were volunteers and participants in the historical recreation of the Battle of Slivnitsa
Numerous spectators attended the traditional restoration of the Battle of Slivnitsa. Many volunteers were involved in the recreation of the events of the Serbo-Bulgarian War of 1885. This year again,
14 November, 2019With Their Traditional Urge for Pioneering Tchaikapharma Supports Innovative Causes
Bulgaria’s Young Talents in The Field of Synthetic Biology Expressed Their Gratitude for The Support Provided Tchaikapharma High Quality Medicines Ltd. supports Bulgaria’s Team of Synthetic Biology yo
23 October, 2019IQVIA: Tchaikapharma is one of the leaders in the prescription drug market
Tchaikapharma High Quality Medicines ranks among the leaders in the Prescription Drugs (Rx) market for the past 12 months (as of June 2019). The ranking “Top 10 Corporations in the market for prescrip
23 October, 2019The registration procedures have been completed and Marketing Authorizations are to be issued for three new products
By the end of 2018, Tchaikapharma expects to be issued with Marketing Authorizations for three new prescription drugs, which will enrich the portfolio and the well-developed therapeutic baskets of the
18 September, 2018Tchaikapharma successfully completed the clinical trials of new dual-component fixed-dose pharmaceutical products
Tchaikapharma completed the bioequivalence clinical trials of 4 new dual-component pharmaceutical products for the treatment of arterial hypertension and other cardiovascular diseases – with sucsess.
12 September, 2018Pizona Combi 15mg/850mg film – coated tablets – the medicine for Type 2 Diabetes treatment is the new medicinal product of “Tchaikapharma High Quality Medicines” Inc., which has been authorized by the Bulgarian Drug Agency (BDA)
Pizona Combi contains pioglitazone and metformin that controls blood sugar levels. It helps the body to utilize better produced by body insulin when metformin alone is insufficient. The medicinal prod
03 May, 2018Tchaikapharma participates in the annual meeting of young doctors and a scientific conference in Pleven
The 33rd National Meeting of the Association of Medical Students in Bulgaria was held in Pleven from 16 to 18 March with the support of Tchaikapharma. A specially designed booth will welcome the parti
29 March, 2018Tchaikapharma has been awarded in Budapest
Tchaikapharma has won award in the category of solution providers during the Pharm Connect congress which is the most notable meeting of leading pharmaceutical and biotechnology companies for Central
14 March, 2018Tchaikapharma was granted Marketing Authorization for the cardiological medicinal product Ivabenor
The newest addition to Tchaikapharma High Quality Medicines Inc. product list is Ivabenor 5 mg and 7,5 mg film-coated tablets. The cardiological medicinal product contains the active substance ivabrad
21 April, 2017Happy Easter!
Tchaikapharma High Quality Medicines Available for All wishes you a Happy Easter!
13 April, 2017How are the medicinal products made at Tchaikapharma’s plant in Plovdiv?
Interview with the production manager at Tchaikapharma’s plant in Plovdiv – Vasil Pavlov. The requirements for the production of medicinal products resulting from the GMP (good manufacturing pr
24 March, 2017Happy National Day!
Tchaikapharma High Quality Medicines has been the first choice of Bulgarian doctors for 18 years.
03 March, 2017Pemetrexed-Tchaikapharma is the newest oncological product of the company with a Marketing Authorization
Tchaikapharma High Quality Medicines Inc. received another Marketing Authorization by the Bulgarian Drug Agency with which the company updated its list of injectable products. The new oncological drug
20 February, 2017The Bulgarian Drug Agency issued a new Marketing Authorisation for Bortezomib-Tchaikapharma
Bortezomib-Tchaikapharma 3.5 mg powder for solution for injection is Tchaikapharma High Quality Medicines’ newest medicinal product which obtained a Marketing Authorisation by the Bulgarian Drug Agenc
09 February, 2017Lidocaine-Tchaikapharma is the company’s newest product with a marketing authorization issued by BDA
Lidocaine-Tchaikapharma 10 mg and 20 mg solution for injection is Tchaikapharma’s newest product which has obtained a Marketing Authorization issued by the Bulgarian Drug Agency. Therapeutic indicatio
02 February, 2017- 23 December, 2016
A Business Ranking distinguished Tchaikapharma among the most profitable and influential companies in Bulgaria
The renowned business ranking “300 Business Leaders in Bulgaria” for one more year honoured Tchaikapharma High Quality Medicines Inc. as one of the most profitable and influential companie
23 November, 2016The Bulgarian Drug Agency authorized medicinal product Cilapenem of Tchaikapharma
The newest product of Tchaikapharma High Quality Medicines Inc., which BDA gave a marketing authorisation for, is Cilapenem 500 mg/500 mg powder for infusion solution. Each phial contains the followin
15 November, 2016The Bulgarian Drug Agency issued a new marketing authorization for the medicinal product Linezolid-Tchaikapharma
The newest medicinal product placed on the market after having received a marketing authorization from the Bulgarian Drug Agency by the Ministry of Health is the infusion solution Linezolid-Tchaikapha
07 November, 2016Cardesart-Co is Tchaikapharma’s new medicinal product, which is now available on the Bulgarian pharmaceutical market
On the Bulgarian pharmaceutical market the latest addition to constantly growing product list of Tchaikapharma High Quality Medicines Inc. for the treatment of cardiovascular diseases is offered from
02 September, 2016After consecutive successful international procedure Tchaikapharma received Marketing Authorisation for the medicinal product Tamayra, for which Bulgaria is the country of reference.
After successfully completing the third for the company Decentralised Procedure (DCP) Tchaikapharma High Quality Medicines Inc. received Marketing Authorisation for the medicinal product Tamayra 5 mg/
19 July, 2016The Bulgarian Drug Agency issues a new marketing authorisation for Tchaikapharma’s medicinal product Ibodria
Tchaikapharma High Quality Medicines Inc. was granted Marketing Authorisations for the medicinal products Ibodria 6 mg/6 ml concentrate for solution for infusion and Ibodria 3 mg/3 ml solution for inj
14 July, 2016Tchaikapharma’s Amariton won the Award for best Bulgarian medicinal product subject to medicinal prescription
The Bulgarian Pharmaceutical Union awarded Tchaikapharma High Quality Medicines Inc. for cardiological medicinal product Amariton in the category “Medicinal Product Subject to Medicinal Prescription –
30 June, 2016Atorva is the new product of Tchaikapharma with Marketing Authorisation.
Tchaikapharma High Quality Medicines Inc. was granted Marketing Authorisations for the medicinal products Atorva 40 mg and 80 mg film-coated tablets. Each tablet contains the active substance atorvast
27 June, 2016Successful completion of the Decentralised Procedure for the medicinal product Tamayra
On 10/05/2016, the BDA successfully completed within the specified period the first decentralised procedure (DCP) for marketing authorisation of medicinal products for which Bulgaria is the Reference
13 May, 2016- 28 April, 2016
Best wishes for the World Health Day
Dear Colleagues, Happy Holidays! Your everyday efforts to improve people’s health and save people’s lives are and have always been worthy of respect! All impediments we face with combine
07 April, 2016Employees of Commercial League delighted the children from the orphanage in Dolna Banya for Christmas
This year again, employees of Commercial League assumed the role of Santa Claus and delighted the kids from Konstantsa Lyapcheva orphanage in the town of Dolna Banya. More than 20 children were asked
11 January, 2016For a consequitive year Tchaikapharma was honoured in a prestigious rating of Business leaders of Bulgaria
Tchaikapharma High Quality Medicines Inc. was distinguished among the most profitable and influential companies in Bulgaria for the 2014 business rating “300 Business leaders in Bulgaria”. In this yea
20 October, 2015Great Britain cuts treatments with little chance of success to free more money for more effective medicines
The National Health Service in the UK discontinues the coverage of 25 cancer drugs Twenty five drugs that each year give a last chance to patients with cancer – including breast, prostate and co
06 October, 2015Doctors, patients, hospitals and human rights activists filed a declaration against the limits in healthcare
The participants in the National Round Table on Reforms and Healthcare without Restrictions insist that the government restores the principle “the funding follows the patient” “We do
06 October, 2015Free cardiac examinations to mark the World Heart Day
The specialized hospitals of the Bulgarian Cardiac Institute in Varna, Veliko Tarnovo, Shumen and Yambol mark the World Heart Day with an appeal for prevention and free consultations Every year on the
06 October, 2015Scientists test the drug metformin, which probably prolongs life
For the first time clinical trials will be conducted to check if a drug prolonged life, said magazine Sciences et Avenir. The medicine in question is metformin, which is often administered to patient
02 October, 2015Pharmacies to be located in small towns by force?
According to Minister Moskov, when one has a facility in the big city where people have assets, one has to take responsibility for the system as well. According to the guild, the solution is to permit
02 October, 2015Young doctors – with the right to a contract with the Health Fund
Doctors specializing in Medicine will have a right to a contract with the NHIF was decided by the MPs yesterday, when they accepted the amendments to the Law on Medical Institutions. This way they mad
02 October, 2015The Parliament Passes the Amendments to the Law on Medical Institutions
The Health Insurance Fund will finance hospitals only according to the needs of the population The Health Insurance Fund will not finance all newfound hospitals and will base its decisions on the Nati
02 October, 2015With the medicinal product of Tchaikapharma Bulgaria for the first time is a reference country in the decentralized procedure
For the first time the Republic of Bulgaria, as a Member State of the EU, will be the reference country in the decentralized procedure (DCP) for Marketing Authorisation for a medicinal products with a
01 September, 2015Tchaikapharma obtained a new Marketing Authorisation for Aroba – a medicinal product for treatment of diabetes
Bulgarian Drug Agency issued a new Marketing Authorisation to Tchaikapharma High Quality Medicines Inc. for the medicinal product for treatment of diabetes mellitus Aroba 100 mg tablets. Aroba contain
14 July, 2015The discovery that two licensed drugs stop dementia gives hope for the therapy of Alzheimer’ disease
The Guardian wrote that the Scientists had found that two licensed drugs stopped the degeneration of the brain in mice. The discovery gives hope of success in the search for drugs for the therapy of A
13 July, 2015A Bulgarian team begins reconstructive breast operations with own fat
Prof. Marita Eisenmann predicted that after 10 years the fat grifting method will completely replace breast implants. Three women after mammectomy due to breast cancer undergo reconstructive surgery t
13 July, 2015SGLT2-inhibitors cause diabetic ketoacidosis
There are reported cases of serious, sometimes life-threatening cases of diabetic ketoacidosis in patients with type 2 diabetes treated with SGLT2-inhibitors. This is reported by the manufacturers aft
13 July, 2015The Health Insurance Fund pays for 22 “orphan drugs”
During the past 2014 the NHIF allocated 72 million for rare medicines The innovations are crucial for achieving better treatment, but they are very expensive. Good examples of this are the so called “
13 July, 2015Minister Moskov proposes: Any economist can head a hospital
A new front in the National Assembly against the reduced requirements for managers was formed. The Health Minister Petar Moskov has proposed a liberalization of the requirements for managers in the Me
13 July, 2015The benefit of statins in peripheral arterial disease
The results of a retrospective study published in the Journal of the American College of Cardiology show that the patients with critical limb ischemia who took statins had a significantly lower incide
13 July, 2015Minister Moskov: The cost of treatment is now like a cat in a sack
At the press conference some days ago the Minister of Health Dr. Peter Moskov stated that at that time the valuation of clinical pathways was like a cat in a bag – no one knew what was in it. He
22 June, 2015Changes in the Health Insurance Act – who saw them how?
The first health reforms initiated by the government are already happening. With the support of the deputies from the parties Patriotic Front and Alternative for Bulgarian Revival last week were adopt
22 June, 2015Metformin and pioglitazone in the treatment of diabetes mellitus type 2
Metformin is the most commonly used anti-diabetic medicine worldwide. It is generally recognized by experts as the first choice diabetic glucose-lowering drug for glycemic diabetes type 2 (DT2) contro
22 June, 2015Nebivolol – the different beta-adrenergic blocker
Nebivolol is a third generation beta-adrenergic receptor blocker with vasodilating properties. It has the highest affinity for beta-1 receptors when compared to other beta-blockers (BB). Due to the le
25 May, 2015Tchaikapharma High Quality Medicines AD will have its own exhibition stand at the Jubilee Conference dedicated to the 10th anniversary of the Department of Cardiac Surgery at the University Hospital “St. Marina” in Varna
June 14, 2015 marks the 10th anniversary from the creation of the Department of Cardiac Surgery at the University Hospital “St. Marina” at the Medical University in Varna “Prof. Dr. Parask
12 May, 2015Tchaikapharma High Quality Medicines Inc. occupies one of the top spots in the rating of the best employers in Bulgaria
The rating system for assessing of the employers is part of a joint project of the CITUB and the Bulgarian Industrial Association. Tchaikapharma High Quality medicines Inc. is rated second in one of t
20 January, 2015Tchaikapharma High Quality Medicines Inc. received Marketing Authorization for Pizona – a new medicine for diabetes
Tchaikapharma High Quality Medicines Inc. received Marketing Authorization for Pizona – a new medicine for diabetes. Tchaikapharma High Quality Medicines Inc. received new Marketing Authorization for
13 January, 2015The team of “Tchaikapharma High Quality Medicines” wishes you warm and happy Christmas and New Year holidays!
The team of “Tchaikapharma High Quality Medicines” wishes you warm and happy Christmas and New Year holidays!
16 December, 2014The generics make treatment of a larger number of patients possible by releasing funds for innovative therapies without analogue
Interview with Nikolay Hadjidonchev, Chairman of the Bulgarian Generic Pharmaceutical Association “BGPharmA” For two years you are fighting to get a precise breakdown of costs for medicines by the hea
25 November, 2014Dr. Stoycho Katsarov from the Center for Protection of Rights in Healthcare: how to (mis)use power ?!
The situation with the private Cardiology Hospital in Vidin should be recorded in textbooks as an example of how power is misused without punishment – Dr. Katzarov how is power (mis)used without
17 November, 2014Three hospitals refused to admit uninsured woman from Kazanlak
Three hospitals refused to admit for treatment a 47 year-old woman from Kazanlak with acute myocardial infarction. After a whole day of wandering between health facilities Dafinka Boneva was hospitali
12 November, 2014After long judicial proceedings, the state paid BGN 100 000 compensation to wrongly accused doctors
After a 10-month delay the state prosecution paid BGN 100 000 compensation to the three doctors charged in the death of 5-month-old Maria in Pazardzhik hospital seven years ago. Then the child died of
04 November, 2014Why the hospitals are commercial entities? And why not?
Comments by Dr. Stojcho Katzarov, Chairman of the Board of Directors of the Center for Protection of Healthcare Rights. People say: Hospitals are commercial entities and this interferes with medical c
03 November, 2014The government approved physicians to issue electronic medical certificate
At a meeting held last week the government approved amendments to the Regulation on calculation and payment of cash compensation and benefits from public social security related to the introduction fr
03 November, 2014NHIF and cardiovascular specialists have signed an Agreement to control spending on cardiac clinical pathways
The Agreement for cooperation for implementation of effective control over the funds in the field of interventional cardiology and cardiac surgery, was signed last week. The press center of the Fund a
03 November, 2014The BMA notes the Day of the Bulgarian physician with a charity campaign
Today, with a charity campaign in favor of the Fund for treatment of children the Bulgarian Medical Association commemorates the Day of the Bulgarian physician. On October 19, the holiday of St. Ivan
23 October, 2014The BMA wants the physicians to have guaranteed treatment for infections acquired in the workplace
The BMA wants the physicians to have guaranteed treatment for infections acquired in the workplace. This was announced by the Professional Association during the Congress of Nephrology in Hissar. The
23 October, 2014NHIF: There are no problems with the refferals till the end of the year.
There are no problems with the regulatory standards provided for the last quarter of the year. This was announced by the press center of the NHIF in connection with the emerging information that the r
23 October, 2014Cardiologist Assoc. Prof. Sotir Marchev: Stress causes women the terrible disease Taco-tsubo
Assoc. Prof. Dr. Sotir Marchev, MD, was born in 1961 in Blagoevgrad. He graduated with a gold medal from English High School, and then, also with honors, the Medical University in Sofia. He has two sp
15 October, 2014Only five thousand people have requested access to their e-health dossier in 2014
People want control over the health care system, but do not bother to carry it out in person, even if such an opportunity is provided to them. This becomes evident from the report of the NHIF of the i
14 October, 2014The Health Ministry buys 40 000 vaccines without tender
The Health Ministry will purchase almost 40 000 vaccines for a total amount of BGN 4.27 million without a tender, through direct negotiation procedure. The aim is to control the crisis with the 6-vale
14 October, 2014After the moratorium on prices 112 over-the-counter medicines have become more expensive
Among them are some of the best-selling medications for pain, flu and allergies. The result of the imposed antimarket one year moratorium on the increase of prices of the over-the-counter medicines is
14 October, 2014Pharmacists in hospital pharmacies – with contracts of employment with hospitals
All staff working in hospital pharmacies must have an employment contract with the recpective medical facility which opened the pharmacy. This is provided in the draft amendment to the Ordinance No.28
14 October, 2014Community-acquired pneumonia
Community-acquired pneumonia (CAP) is a common infectious disease of the lungs that occurs with significant morbidity and mortality. In Europe and America about 4 million cases of CAP lead to 1 millio
14 October, 2014The elderly people in our country are satisfied with the General Practitioners and pharmacists
The elderly people in our country are satisfied with the General Practitioners and pharmacists, because they in details and clearly explain them the diseases and drug therapies and are considerate and
07 October, 2014The General Practitioners neglect the problem of type 2 diabetes, according to the patient organizations
Vyara Vragova of the patient organization “Type 2 diabetes” said that the General Practitioners neglect the problem of type 2 diabetes. According to her the General Practitioners “do not pay much atte
07 October, 2014The NHIF received cash for the user fees for pensioners and will settle doctors payments for July
The National Health Insurance Fund announced that on the last day of September National it received the funds for this July needed to pay the difference in user fee for pensioners to general practitio
07 October, 2014The employers and the trade unions supported the revised budget of the NHIF, the Confederation of Independent Trade Unions in Bulgaria (CITUB) proposed the fund to be divided into two insurance funds
The employers and the trade unions supported the revised budget of the NHIF proposed by the interim government. The social partners, however, strongly objected against the situation in health care, st
07 October, 2014There are no problems for the General Practitioners to report via the information system of the National Health Insurance Fund (NHIF)
The Gerneral Practitioners can, without problems, report to the NHIF the Immunizations preformed in children despite the changes of the terms of their performance There are no problems for the General
07 October, 2014Useful therapeutic solutions
Levofloxacin monotherapy is highly effective in community-acquired pneumonia Levofloxacin is one of the three respiratory fluoroquinolones that are recommended for empirical treatment of a wide range
07 October, 2014Slivnitsa Municipality sent a thank you letter to Prof. Grigorov and Prof. Vekov on the occasion of the Unification Day of Bulgaria
Mr. Georgi Georgiev, Chairman, Town Council of Slivnitsa Municipality, greeted Prof. Mladen Grigorov, Chairman of the Bulgarian Monuments of Glory Foundation and Prof. Toni Vekov, Member of the Counci
24 September, 2012BFS sent a thank you letter to Tchaikapharma
Tchaikapharma High Quality Medicines Inc. was acknowledged for a consecutive time for its contribution to the development of the pharmaceutical sector in Bulgaria. The Chairman of the Bulgarian Pharma
03 August, 2012Tchaikapharma was awarded one of the most prestigious prizes in Pharmacy – Medicine of the Year for 2012
For the sixth consecutive year the Bulgarian Pharmaceutical Union held the Bulgarian Pharmaceutical Days under the motto “Equal Access to Medicines and Pharmaceutical care”. The event was attended by
16 July, 2012Cocoa, not tea, is your best bet against high blood pressure
This content is currently not available in English.
28 February, 2012How to make the best molecules affordable?
The public stance of Tchaikapharma High Quality Medicines regarding the reimbursement and pharmaceutical policy, effective since 2004 June 10, 2010 In Bulgaria t
12 October, 2010Tchaikapharma was granted Marketing Authorization for 3 new Rx products
The newest addition to Tchaikapharma High Quality Medicines Inc. prescription drugs (Rx) product list are the following: – Zornichka (chlorthalidone) – for the treatment of arterial hyper
12 October, 2010Tchaikapharma launches a Bulgarian analogue of a popular cancer drug
In the last nine years Tchaikapharma High Quality Medicines Affordable for Everyone has earned its reputation as one of the main Bulgarian pharmaceutical manufacturers with the fastest development rat
12 October, 2010Schizophrenia drug health risk
[:en]Patients who take the antipsychotic drug clozapine risk a group of health conditions called metabolic syndrome, researchers warn. Metabolic syndrome's cluster of obesity, high blood glucose level
12 October, 2010Humidity raises heart attack risk in the elderly
[:en] High humidity can increase the risk of a heart attack in the elderly even in relatively mild climates, according to the study “Climate Impacts on Myocardial infarction deaths in the Athens Terri
22 July, 2006
